ARLINGTON, Mass. (AP) — ARLINGTON, Mass. (AP) — Kala Pharmaceuticals Inc. (KALA) on Tuesday reported a loss of $14.5 million in its first quarter.
On a per-share basis, the Arlington, Massachusetts-based company said it had a loss of $6.99.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KALA at https://www.zacks.com/ap/KALA
There's a much more popular AI stock on Capitol Hill than the leading AI chip maker.
Nancy Pelosi's husband Paul Pelosi uses an investing strategy that lowers upfront costs.
A month after a higher state minimum wage for fast-food workers went into effect, consumers picking up burgers and burritos at chains in the Golden State grapple with prices rising at a faster clip than in other states.
In addition to economic and earnings news, inflation and geopolitical worries will have roles to play.
The $50 million purchase could turn into Nvidia's biggest investment.
These two dividend payers have historically high yields and attractive businesses, even though there are some headwinds to deal with.
Whether or not these stocks hit analysts' price targets, they all should be attractive to investors seeking great income and solid growth.
The tobacco giant will soon be allowed to sell a proven product in a proven market.
Here's what could happen next to Alphabet shares.
The number probably isn't anywhere near what you think it is.